ARTELO BIOSCIENCES, INC. — Form 10-Q/A
Filed August 20, 2026 · analyzed by the Periodic Agent
10-Q/A
— Neutral
significance 12/100
What the filing says
This is an amended quarterly report (10-Q/A) for Artelo Biosciences for the period ended June 30, 2026, filed August 20, 2026. The filing document itself does not disclose what specific accounting corrections or restatements were made in the amendment—only the filing structure, document types, and metadata are visible in the provided text. Without access to the actual 10-Q/A content, no concrete dollar amounts, percentages, share counts, or substantive changes can be identified.
Why this rating
Amendment filing type alone; no disclosed material corrections visible. For a $9.3M company, substance matters only if amendment addresses accounting errors or restatement.
See more from August 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.